4 years ago

PI3K-Akt pathway enhances the differentiation of interleukin-27-induced type 1 regulatory T cells

PI3K-Akt pathway enhances the differentiation of interleukin-27-induced type 1 regulatory T cells
Niken Adiba Nadya, Shigenori Nagai, Satoshi Matsuda, Miyuki Azuma, Hiroyuki Tezuka, Toshiaki Ohteki
Interleukin 27 (IL-27) has been identified as a potent cytokine in the differentiation of type 1 regulatory T (Tr1) cells through interactions with several key elements, including transcription factors such as aryl hydrocarbon receptor and IL-21. Autocrine production of IL-21 is known to be important for maintaining IL-10 expression by Tr1 cells. Although previous studies have shown that the phosphoinositide 3-kinase (PI3K) –Akt axis contributes to the differentiation of helper T-cell subsets, the role of the PI3K pathway on Tr1 cell differentiation remains to be elucidated. Here, we demonstrate that suppression of the PI3K-Akt pathway results in impairment of IL-27-induced Tr1 (IL-27–Tr1) cell differentiation in vitro and in vivo. Furthermore, this suppression down-regulates IL-21 receptor expression by Tr1 cells, followed by suppression of IL-10 expression by IL-27–Tr1 cells. These results suggest that the PI3K pathway enhances IL-10 expression by IL-27–Tr1 cells through up-regulation of IL-21 receptors. The inhibition of phosphoinositide 3-kinase (PI3K) pathway suppresses interleukin-10 (IL-10) expression by IL-27-induced type 1 regulatory T (IL-27–Tr1) cells and this inhibition negatively regulates IL-21 receptor expression on IL-27–Tr1 cells despite the abundance of IL-21. We demonstrated the importance of the PI3K-Akt pathway in the differentiation of IL-27–Tr1 cells through the up-regulation of IL-21 receptors.

Publisher URL: http://onlinelibrary.wiley.com/resolve/doi

DOI: 10.1111/imm.12789

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.